Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.4T | 5.5T | 5.4T | 5.4T |
Cost of revenue | 4.2T | 4.4T | 4.2T | 4.2T |
Gross profit | 1.1T | 1.2T | 1.1T | 1.2T |
Operating expense | ||||
Research & development | 353.3B | 267.7B | 262.7B | 215.9B |
Selling general and admin | 711.2B | 514.8B | 629.3B | 495.8B |
Other operating expenses | — | — | — | — |
Operating income | 73.6B | 397.3B | 257.9B | 484.7B |
Non operating interest income | ||||
Income | 40.3B | 50.1B | 50.6B | 50.1B |
Expense | 16.9B | 13.0B | 12.8B | 12.2B |
Other income expense | -3.5B | -6.5B | -22.2B | 1.4B |
Pretax income | 92.1B | 483.6B | 182.5B | 559.5B |
Tax provision | 49.5B | 150.0B | 70.0B | 145.1B |
Net income | 42.6B | 333.6B | 112.5B | 414.3B |
Basic EPS | — | — | — | 81.8 |
Diluted EPS | — | — | — | 81.8 |
Basic average shares | — | — | — | 4.8B |
Diluted average shares | — | — | — | 4.8B |
EBITDA | 303.8B | 677.8B | 374.1B | 759.6B |
Net income from continuing op. | 92.1B | 483.6B | 182.5B | 559.5B |
Minority interests | -12.0B | -23B | -12.5B | -19.7B |
Preferred stock dividends | — | — | — | — |